JULIA HAINSWORTH: Open Payments
NPI 1528764198 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 19 payments from 9 companies in 2025. Trend: 2023 $125 · 2024 $259 · 2025 $502
Food & beverage: $427Education: $75
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $125 |
| Incyte Corporation | 2 | $92 |
| Janssen Biotech, Inc. | 3 | $81 |
| PFIZER INC. | 2 | $59 |
| Daiichi Sankyo Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $35 |
| GENZYME CORPORATION | 1 | $29 |
| Astellas Pharma US Inc | 1 | $17 |
| Tempus AI, Inc | 1 | $14 |
Products named: KEYTRUDA, IBRANCE, RYBREVANT, TALVEY, SARCLISA, DATROWAY, LYNPARZA, Enhertu.
Industry payments across NY — which companies pay providers there.
